Literature DB >> 27943149

Utility of Microdialysis in Infectious Disease Drug Development and Dose Optimization.

Amelia N Deitchman1, M Tobias Heinrichs1, Vipada Khaowroongrueng1, Satyawan B Jadhav1, Hartmut Derendorf2.   

Abstract

Adequate drug penetration to a site of infection is absolutely imperative to ensure sufficient antimicrobial treatment. Microdialysis is a minimally invasive, versatile technique, which can be used to study the penetration of an antiinfective agent in virtually any tissue of interest. It has been used to investigate drug distribution and pharmacokinetics in variable patient populations, as a tool in dose optimization, a potential utility in therapeutic drug management, and in the study of biomarkers of disease progression. While all of these applications have not been fully explored in the field of antiinfectives, this review provides an overview of how microdialysis has been applied in various phases of drug development, a focus on the specific applications in the subspecialties of infectious disease (treatment of bacterial, fungal, viral, parasitic, and mycobacterial infections), and developing applications (biomarkers and therapeutic drug management).

Entities:  

Keywords:  antibiotics; antivirals; drug penetration; pharmacodynamics; pharmacokinetics

Mesh:

Substances:

Year:  2016        PMID: 27943149     DOI: 10.1208/s12248-016-0020-1

Source DB:  PubMed          Journal:  AAPS J        ISSN: 1550-7416            Impact factor:   4.009


  92 in total

1.  Single-dose pharmacokinetics of vancomycin in porcine cancellous and cortical bone determined by microdialysis.

Authors:  Mats Bue; Hanne Birke-Sørensen; Theis M Thillemann; Tore F Hardlei; Kjeld Søballe; Mikkel Tøttrup
Journal:  Int J Antimicrob Agents       Date:  2015-07-28       Impact factor: 5.283

2.  Antibacterial antibodies gain traction.

Authors:  Chris Morrison
Journal:  Nat Rev Drug Discov       Date:  2015-11       Impact factor: 84.694

3.  Skeletal muscle and plasma concentrations of cefazolin during cardiac surgery in infants.

Authors:  Adam S Himebauch; Susan C Nicolson; Martha Sisko; Ganesh Moorthy; Stephanie Fuller; J William Gaynor; Athena F Zuppa; Elizabeth Fox; Todd J Kilbaugh
Journal:  J Thorac Cardiovasc Surg       Date:  2014-07-22       Impact factor: 5.209

4.  Optimization of perfusate pH to improve microdialysis recovery of lipophilic compounds.

Authors:  Emmanuelle S Tre; Chanchal Patel; Shiv Aghara; Chirag Yadav; Grazia Stagni
Journal:  J Pharmacol Toxicol Methods       Date:  2012-08-03       Impact factor: 1.950

5.  Quantitative determination of unbound cefoperazone in rat bile using microdialysis and liquid chromatography.

Authors:  Yuh-Lih Chang; Shih-Hwa Chiou; Yueh-Ching Chou; Chih-Ju Yen; Tung-Hu Tsai
Journal:  J Pharm Biomed Anal       Date:  2007-05-06       Impact factor: 3.935

6.  Free renal levels of voriconazole determined by microdialysis in healthy and Candida sp.-infected Wistar rats.

Authors:  Bibiana Verlindo de Araujo; Cristófer Farias da Silva; Sandra Elisa Haas; Teresa Dalla Costa
Journal:  Int J Antimicrob Agents       Date:  2008-11-17       Impact factor: 5.283

7.  Roles of inner blood-retinal barrier organic anion transporter 3 in the vitreous/retina-to-blood efflux transport of p-aminohippuric acid, benzylpenicillin, and 6-mercaptopurine.

Authors:  Ken-ichi Hosoya; Akihide Makihara; Yuki Tsujikawa; Daisuke Yoneyama; Shinobu Mori; Tetsuya Terasaki; Shin-ichi Akanuma; Masatoshi Tomi; Masanori Tachikawa
Journal:  J Pharmacol Exp Ther       Date:  2008-12-30       Impact factor: 4.030

8.  Soft tissue penetration of cefuroxime determined by clinical microdialysis in morbidly obese patients undergoing abdominal surgery.

Authors:  April Barbour; Stephan Schmidt; W Robert Rout; Kfir Ben-David; Olaf Burkhardt; Hartmut Derendorf
Journal:  Int J Antimicrob Agents       Date:  2009-05-02       Impact factor: 5.283

Review 9.  Population pharmacokinetics meets microdialysis: benefits, pitfalls and necessities of new analysis approaches for human microdialysis data.

Authors:  André Schaeftlein; Iris K Minichmayr; Charlotte Kloft
Journal:  Eur J Pharm Sci       Date:  2013-11-15       Impact factor: 4.384

Review 10.  Cerebral microdialysis in clinical studies of drugs: pharmacokinetic applications.

Authors:  Richard J Shannon; Keri L H Carpenter; Mathew R Guilfoyle; Adel Helmy; Peter J Hutchinson
Journal:  J Pharmacokinet Pharmacodyn       Date:  2013-03-07       Impact factor: 2.745

View more
  5 in total

1.  Moxifloxacin target site concentrations in patients with pulmonary TB utilizing microdialysis: a clinical pharmacokinetic study.

Authors:  M Tobias Heinrichs; Sergo Vashakidze; Ketino Nikolaishvili; Irina Sabulua; Nestani Tukvadze; Nino Bablishvili; Shota Gogishvili; Brent P Little; Adam Bernheim; Jeannette Guarner; Charles A Peloquin; Henry M Blumberg; Hartmut Derendorf; Russell R Kempker
Journal:  J Antimicrob Chemother       Date:  2018-02-01       Impact factor: 5.790

2.  Therapeutic Drug Monitoring of Anti-infective Drugs: Implementation Strategies for 3 Different Scenarios.

Authors:  Hannah Yejin Kim; Kenneth C Byashalira; Scott K Heysell; Anne-Grete Märtson; Stellah G Mpagama; Prakruti Rao; Marieke G G Sturkenboom; Jan-Willem C Alffenaar
Journal:  Ther Drug Monit       Date:  2022-02-01       Impact factor: 3.118

3.  Is the penetration of clindamycin into the masseter muscle really enough to treat odontogenic infections?

Authors:  Paula I Faggion; Gabriela Isoton; Eduarda Possa; Leandro Tasso
Journal:  Clin Oral Investig       Date:  2020-10-31       Impact factor: 3.573

Review 4.  Model-Informed Drug Development for Anti-Infectives: State of the Art and Future.

Authors:  Craig R Rayner; Patrick F Smith; David Andes; Kayla Andrews; Hartmut Derendorf; Lena E Friberg; Debra Hanna; Alex Lepak; Edward Mills; Thomas M Polasek; Jason A Roberts; Virna Schuck; Mark J Shelton; David Wesche; Karen Rowland-Yeo
Journal:  Clin Pharmacol Ther       Date:  2021-03-09       Impact factor: 6.875

Review 5.  Time to 'Mind the Gap' in novel small molecule drug discovery for direct-acting antivirals for SARS-CoV-2.

Authors:  Colleen B Jonsson; Jennifer E Golden; Bernd Meibohm
Journal:  Curr Opin Virol       Date:  2021-06-29       Impact factor: 7.090

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.